Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to Know
Creator
Fiona Costello, MD, FRCP
Affiliation
Professor, Departments of Clinical Neurosciences and Surgery, Associate Dean of Chairs and Professorships, Cumming School of Medicine, University of Calgary, Calgary, Alberta
The discovery of targeted immunotherapies has changed the clinical course and long term prognosis for people living with a variety of conditions including neuromuscular diseases, inflammatory disorders of the central nervous system (CNS), and specific cancers. While many of these therapies have advanced the care of our patients, their use may sometimes lead to deleterious side effects. This presentation will highlight complications of immunotherapies relevant to Neuro-ophthalmic practice.
Date
2023-03
References
Professor, Departments of Clinical Neurosciences and Surgery, Associate Dean of Chairs and Professorships, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2023 North American Neuro-Ophthalmology Society Annual Meeting
